What industry does ClavystBio belong to?

ClavystBio is in the industry of: Investment Management, Venture Capital & Private Equity, Biotechnology.

What tech stack does ClavystBio use?

Some of the popular technologies that ClavystBio uses are: Cloudflare, Craft CMS, reCAPTCHA.

What are ClavystBio's office addresses?

ClavystBio has 2 known office addresses: 79 Science Park Drive #04-05 Cintech IV, Singapore Science Park Singapore, 118264, SG 79 Science Park Drive, #04-05 Cintech Iv, Singapore Science Park, Singapore, 118264, Sg.

What is ClavystBio's estimated annual revenue?

ClavystBio's revenue is $1,000,000

What is ClavystBio's open headcount?

ClavystBio has no job postings yet.

What is the number of ad campaigns for ClavystBio?

ClavystBio has 4 advertisements.

What is the number of recent news articles about ClavystBio?

ClavystBio has 3 news articles.

ClavystBio - Pubrio Company Profile & Intent

ClavystBio

Singapore · Investment Management

Investment Management

Venture Capital & Private Equity

Biotechnology

ClavystBio's mission is to accelerate the commercialization of life sciences breakthroughs into health impact. We invest and partner with innovators, entrepreneurs and founders to launch and grow global companies in Singapore. We foster partnerships among academics, industry and investors, and convene life sciences communities at our collaborative innovation space Node 1. Together, we advance Singapore as a global life sciences translational hub. ClavystBio was conceived and launched by Temasek to be a venture builder, trusted partner, and keystone to catalyze global health solutions from Singapore. Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics and digital health companies, as well as early-stage VC funds.

Company Insights

Category and Technology

Implementation Date

Last Recorded

CDN
- Cloudflare
  http://www.cloudflare.com
  February 8, 2025
  -
CMS
- Craft CMS
  https://craftcms.com/
  September 29, 2024
  -
Security
- reCAPTCHA
  https://www.google.com/recaptcha/
  February 20, 2025
  -

Advertising
- Google AdSense
  https://www.google.com/adsense/start/
  August 2, 2025
  -
- Twitter Ads
  https://ads.twitter.com
  August 2, 2025
  -
- Amazon Advertising
  https://advertising.amazon.com
  August 2, 2025
  -
- Microsoft Advertising
  https://ads.microsoft.com
  August 2, 2025
  -
- Google Publisher Tag
  https://developers.google.com/publisher-tag/guides/get-started
  August 2, 2025
  -
- Prebid
  http://prebid.org
  August 2, 2025
  -
- DoubleClick Floodlight
  http://support.google.com/ds/answer/6029713?hl=en
  February 8, 2026
  -
- DoubleClick Campaign Manager (DCM)
  http://www.doubleclickbygoogle.com/solutions/digital-marketing/campaign-manager/
  August 2, 2025
  -
- ID5
  https://id5.io/
  August 2, 2025
  -

Get full access to view complete information

2026-01-28

Open job

Director, AI Enablement

Coindesk · London, England, United Kingdom

2025-09-05

Open job

Senior Security Operations Analyst

Coindesk · Frankfurt, Hesse, Germany

2025-10-08

Open job

News Reporter

Coindesk · Almada, Setúbal, Portugal

Get full access to view complete information

1 - 0 of 0

linkedin · Started 2/23/2026

Our portfolio company Leyden Labs has published positive data demonstrating that intranasal delivery of their pan-influenza antibody can be safely achieved in humans and reach protective levels at the site of viral entry. 🎉This marks a critical step toward a first-in-class product category for protection against respiratory virus infections. Congratulations to Koenraad Wiedhaup, Clarissa K., and the entire Leyden Labs team on this important milestone!🔗 Read more here:https://lnkd.in/gcT_TJWB A ...

Clavystbio

linkedin · Started 2/23/2026

Clavystbio

linkedin · Started 1/15/2026

From breakthrough science to real-world patient impact.Innovation from Asia is a new global force in health. To scale and deliver these cures to patients worldwide, founders need a trusted partner.Backed by Temasek, ClavystBio partners with scientists and founders to build and scale biotech, medtech and digital health ventures from Asia to the world.Follow ClavystBio to see how research transforms into real-world impact👇 ...

Clavystbio

linkedin · Started 2/13/2026

Open ad

Stellar’s Bet: Real-World Finance, Not Hype

Coindesk

linkedin · Started 1/1/2026

Coindesk

linkedin · Started 12/25/2025

Open ad

Position Your Brand at the Center of Web3

Coindesk

Get full access to view complete information

1 - 4 of 4

manilatimes.net · receives_financing · 2025-07-23

Open news

Respiree raises $11.6M in Series A funding

Respiree secures $11.6M in Series A funding led by We Venture Capital and ClavystBio, boosting its respiratory health technology development.

We Venture Capital

Respiree

Clavystbio

prnasia.com · partners_with · 2025-06-10

Open news

ClavystBio and A*STAR partner for MedTech ventures

ClavystBio and A*STAR sign MoU to create and grow MedTech ventures in Singapore, focusing on venture creation, product development, and commercialization.

Singapore Economic Development Board

Dxd Hub - Diagnostics Development Hub

Clavystbio

Temasek

prnasia.com · receives_financing · 2025-03-03

Open news

Callio Therapeutics launches with $187M Series A funding

Callio Therapeutics launches with $187M Series A funding to develop multi-payload ADCs for cancer treatment, led by Frazier Life Sciences.

Omega Funds

Frazier Life Sciences

Pureos Bioventures

Seedscapital.Com

Edbi Pte Ltd

Norwest Industries Pvt.Ltd

Clavystbio

Novo-Nordisk A/S

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

Coindesk

Deribit

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

Coindesk

Upbit Singapore

coinreaders.com · launches · one week ago

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Coindesk

J.P. Morgan

Get full access to view complete information

1 - 3 of 3

Get full access to view complete information

Frequently Asked Questions Regarding ClavystBio

Company Overview

2022

Founded

Investment Management

Industry

Singapore

Location

5,162,637

Ranking

24 employees

Size

Similar Companies

Get full access to view complete information

Company Insights

CDN

CMS

Security

Advertising

Frequently Asked Questions Regarding ClavystBio

How many employees does ClavystBio have?

What industry does ClavystBio belong to?

What does ClavystBio do?

What are ClavystBio's official social media profiles?

What tech stack does ClavystBio use?

What are ClavystBio's office addresses?

What is ClavystBio's estimated annual revenue?

What is ClavystBio's open headcount?

What is the number of ad campaigns for ClavystBio?

What is the number of recent news articles about ClavystBio?

Company Overview

Similar Companies

Frequently Asked Questions Regarding ClavystBio

How many employees does ClavystBio have?

What industry does ClavystBio belong to?

What does ClavystBio do?

What are ClavystBio's official social media profiles?

What tech stack does ClavystBio use?

What are ClavystBio's office addresses?

What is ClavystBio's estimated annual revenue?

What is ClavystBio's open headcount?

What is the number of ad campaigns for ClavystBio?

What is the number of recent news articles about ClavystBio?